|
|
Alexandra Zanin-Zhorov, Liora Cahalon, Guy Tal, Raanan Margalit, Ofer Lider, Irun R. Cohen
J Clin Invest. 2006;
116(7):2022
doi:10.1172/JCI28423
Abstract |
Full text
| PDF

C
D4+CD25+ Tregs regulate immunity, but little is known about their own regulation. We now report that the human 60-kDa heat shock protein (HSP60) acts as a costimulator of human Tregs, both CD4+CD25int and CD4+CD25hi. Treatment of Tregs with HSP60, or its peptide p277, before anti-CD3 activation significantly enhanced the ability of relatively low concentrations of the Tregs to downregulate CD4+CD25– or CD8+ target T cells, detected as inhibition of target T cell proliferation and IFN-γ and TNF-α secretion. The enhancing effects of HSP60 costimulation on Tregs involved innate signaling via TLR2, led to activation of PKC, PI3K, and p38, and were further enhanced by inhibition of ERK. HSP60-treated Tregs suppressed target T cells both by cell-to-cell contact and by secretion of TGF-β and IL-10. In addition, the expression of ERK, NF-κB, and T-bet by downregulated target T cells was inhibited. Thus, HSP60, a self-molecule, can downregulate adaptive immune responses by upregulating Tregs innately through TLR2 signaling.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(99)
| Title and authors |
Publication |
Year |
HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer
Clarissa A. Wild, Sven Brandau, Ramin Lotfi, Stefan Mattheis, Xiang Gu, Stephan Lang, Christoph Bergmann
|
Oral Oncology
|
2012 |
Simultaneous TLR2 inhibition and TLR9 activation synergistically suppress tumor metastasis in mice
Jun Yan, Fang Hua, Han-zhi Liu, Hong-zheng Yang, Zhuo-wei Hu
|
Acta Pharmacol Sin
|
2012 |
Toll-like receptors in rheumatic diseases: Are we paying a high price for our defense against bugs?
K.C.M. Santegoets, L. van Bon, W.B. van den Berg, M.H. Wenink, T.R.D.J. Radstake
|
FEBS Letters
|
2011 |
The HSP60 immune system network
Francisco J. Quintana, Irun R. Cohen
|
Trends in Immunology
|
2011 |
Recombinant Wolbachia heat shock protein 60 (HSP60) mediated immune responses in patients with lymphatic filariasis
Chandanapurath Shiny, Nagampalli S.A. Krushna, Subash Babu, S. Elango, Guruswamy Manokaran, Rangarajan Badri Narayanan
|
Microbes and Infection
|
2011 |
Tick saliva regulates migration, phagocytosis, and gene expression in the macrophage-like cell line, IC-21
Carolyn D. Kramer, Nina M. Poole, Lewis B. Coons, Judith A. Cole
|
Experimental Parasitology
|
2011 |
Distinct Inflammatory Signals Have Physiologically Divergent Effects on Epigenetic Regulation of Foxp3 Expression and Treg Function
G. Lal, N. Yin, J. Xu, M. Lin, S. Schroppel, Y. Ding, I. Marie, D. E. Levy, J. S. Bromberg
|
Am J Transplant
|
2011 |
TLR2 signaling improves immunoregulation to prevent type 1 diabetes
Christophe M. Filippi, Katrin Ehrhardt, Elizabeth A. Estes, Par Larsson, Janine E. Oldham, Matthias G. von Herrath
|
Eur. J. Immunol.
|
2011 |
Mouse and human intestinal immunity: same ballpark, different players; different rules, same score
D L Gibbons, J Spencer
|
Mucosal Immunol
|
2011 |
An altered peptide ligand corresponding to a novel epitope from heat-shock protein 60 induces regulatory T cells and suppresses pathogenic response in an animal model of adjuvant-induced arthritis
Maria del Carmen Dominguez, Noraylis Lorenzo, Ariana Barbera, Guillaume Darrasse-Jeze, Maria Victoria Hernández, Ana Torres, Isabel Hernández, Rafael Gil, David Klatzmann, Gabriel Padrón
|
Autoimmunity
|
2011 |
|